
10,000+ employees
Founded 1897
🧬 Biotechnology
💊 Pharmaceuticals
🏭 Manufacturing
💰 $444.8M Post-IPO Debt - Lonza on 2023-11
Biotechnology • Pharmaceuticals • Manufacturing
Lonza is a Swiss-based, global contract development and manufacturing organization (CDMO) and life sciences company. It provides integrated end-to-end offerings across biologics and small-molecule drug development and manufacturing — including cell line development, process and analytical development, formulation and primary packaging, drug substance and drug product manufacturing, and regulatory/CMC support. Lonza's capabilities span advanced synthesis and APIs (including HPAPIs), bioconjugation and ADCs, specialized modalities such as cell & gene therapies, mRNA/LNP, microbial processes, and capsule and health-ingredient products. Founded in Switzerland in 1897, Lonza describes itself as a pioneer and world leader in the CDMO industry and operates with ~20,000 colleagues across five continents to support pharmaceutical and biotech customers.
Selected: 🇬🇧 United Kingdom – Remote (UK).
Selected: 🆕 Date Added.
🕒 August 9
Associate Director driving EMEA business development for Lonza’s pharmaceutical and biologics manufacturing services. Building strategic partnerships and closing complex customer opportunities remotely across the UK.
🇬🇧 United Kingdom – Remote
💰 $444.8M Post-IPO Debt - Lonza on 2023-11
⏰ Full Time
🟠 Senior
💰 Business Development (BDR)
👻 Ghost score 20%